Sponsor Pipeline

ARCE Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06680752 Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS Acute Myeloid Leukemia, in Relapse Recruiting
Not specified
NCT06906380 A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies Acute Myeloid Leukemia, in Relapse Not Yet Recruiting
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Myelodysplastic Syndromes (MDS) (2)
Get alerts when ARCE Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free